Novacyt (ALNOV) — Cash Flow-to-Debt Ratio
Novacyt (ALNOV) has a Cash Flow-to-Debt Ratio of -0.19x as of December 2025, meaning its operating cash flow of €-3.28 Million could theoretically repay 0% of its total liabilities (€16.94 Million) in one year. See financial flexibility index of Novacyt to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Novacyt Cash Flow-to-Debt Ratio (2009–2025)
Historical debt coverage capacity for Novacyt across 17 annual periods. For the full cash flow conversion analysis, see Novacyt (ALNOV) cash conversion ratio.
Annual Cash Flow-to-Debt Ratio for Novacyt (2009–2025)
Year-by-year debt coverage analysis for Novacyt. Check Novacyt earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.52x | €-8.76 Million | €16.94 Million | ▼ -38.5% |
| 2024 | -0.37x | €-8.49 Million | €22.75 Million | ▲ +30.5% |
| 2023 | -0.54x | €-24.99 Million | €46.57 Million | ▼ -0.4% |
| 2022 | -0.53x | €-13.73 Million | €25.68 Million | ▼ -242.7% |
| 2021 | 0.37x | €15.69 Million | €41.88 Million | ▼ -69.6% |
| 2020 | 1.23x | €102.98 Million | €83.57 Million | ▲ +1991.6% |
| 2019 | -0.07x | €-916.70K | €14.07 Million | ▲ +35.3% |
| 2018 | -0.10x | €-1.12 Million | €11.16 Million | ▲ +80.3% |
| 2017 | -0.51x | €-4.12 Million | €8.09 Million | ▼ -152.5% |
| 2016 | -0.20x | €-2.18 Million | €10.80 Million | ▲ +66.3% |
| 2015 | -0.60x | €-3.95 Million | €6.57 Million | ▼ -463.4% |
| 2014 | -0.11x | €-678.92K | €6.37 Million | ▲ +91.4% |
| 2013 | -1.24x | €-1.07 Million | €862.25K | ▼ -980.8% |
| 2012 | -0.12x | €-225.28K | €1.96 Million | ▲ +60.0% |
| 2011 | -0.29x | €-576.20K | €2.00 Million | ▼ -2437.3% |
| 2010 | 0.01x | €33.77K | €2.75 Million | ▲ +104.5% |
| 2009 | -0.27x | €-705.19K | €2.57 Million | — |